EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Protective effect of glyburide on wound healing in streptozotocin-induced diabetic rats via alteration of NF-κB/transforming growth factor-β and cellular jun/platelet-derived growth factor-vascular endothelial growth factor signaling pathways

Schützender Effekt von Glyburid auf die Wundheilung bei streptozotocin-induzierten diabetischen Ratten über die Veränderung von NF-κB/transforming growth factor-β- und c-Jun/platelet-derived growth factor-vascular endothelial growth factor-Signalwegen

Xianjun Fu, Fang Wang, Wei Zhang, Wei Li, Xiaohong Sun

Indian Journal of Pharmacology · 2026-11 · 58 (6) · 665-673

DOI: 10.4103/ijp.ijp_133_26 ↗

Auf einen Blick

In einer Tierstudie verbesserte Glyburid die Wundheilung bei streptozotocin-induzierten diabetischen Ratten dosisabhängig. Die Wundfläche nahm ab, Glukosewerte sanken und Insulin stieg.

Fragestellung

Welchen schützenden Effekt hat Glyburid auf die Wundheilung bei streptozotocin-induzierten diabetischen Ratten und welche Signalwege sind beteiligt?

Methode

Experimentelle Studie an Swiss-Wistar-Ratten mit STZ-induziertem Diabetes; orale Gabe von Glyburid in 1,25, 2,5 und 5 mg/kg; Messung von Wundfläche, Stoffwechsel-, Entzündungs- und mRNA-Parametern.

Ergebnisse

Dosisabhängig verringerte Glyburid die Wundfläche, Glukose, Futter- und Wasseraufnahme und erhöhte Körpergewicht und Insulin. Es veränderte Protein-, Kollagen-, oxidativen Stress-, Entzündungs-, Apoptose- und mRNA-Parameter.

Schlussfolgerung der Autor:innen

Die Autoren schließen, dass Glyburid einen schützenden Effekt gegen STZ-induzierten diabetischen Wunddefekt über Veränderungen der NF-κB/TGF-β- und c-Jun/PDGF-VEGF-Signalwege zeigte.

Kernaussagen

  • Dosisabhängige Abnahme der Wundfläche unter Glyburid
  • Veränderungen bei Entzündungs-, Oxidations- und Apoptoseparametern
  • Beteiligung von NF-κB/TGF-β- und c-Jun/PDGF-VEGF-Signalwegen

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Pharmacology, online erschienen am 02.11.2026. Verfasst von Xianjun Fu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic, Burn & Medical Cosmetic Surgery, The First Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Wound Healing, Glyburide, Hypoglycemic Agents. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Diabetes-induced abnormal wound healing is characterized by prolonged oxidative stress, inflammation, and impaired tissue regeneration, largely due to excessive production of oxidative stress and inflammatory mediators. Glyburide is a well-known antidiabetic drug. In this experimental study, we scrutinized the protective effect of glyburide against streptozotocin (STZ) induced wound healing in rats and explored the underlying mechanism. MATERIALS AND METHODS: Swiss Wistar rats were randomly assigned to groups and intraperitoneally injected with STZ to induce diabetes. The rats received the oral administration of glyburide (1.25, 2.5, and 5 mg/kg). We estimated the wound area, body weight, glucose level, insulin level, food intake, water intake, protein, albumin, glucosamine, hydroxyproline, collagen, macrophage migration inhibitory factor (MIF), hexosamine, lipid parameters, antioxidant parameters, apoptosis parameters, inflammatory cytokines, and inflammatory parameters. The mRNA expression levels were estimated in the rats’ skin. RESULTS: Dose-dependent treatment of glyburide decreased the wound area, glucose level, food intake, and water intake, and enhanced the body weight and insulin. Glyburide treatment altered the level of protein, albumin, glucosamine, hydroxyproline, collagen, MIF, hexosamine, lipid parameters (total cholesterol, triglyceride, low-density lipoprotein (LDL), and high-density lipoprotein, very LDL), oxidative stress (malonaldehyde, glutathione, glutathione peroxidase, superoxide dismutase, and catalase), inflammatory cytokines (tumor necrosis factor-α, interleukin-1 β (IL-1 β), IL-6, IL-10, and IL-17), apoptosis parameters (B-cell lymphoma 2 [Bcl-2]-associated X protein [Bax], Bcl-2, cysteine-aspartic acid protease 3 [caspase-3]), inflammatory parameters (cyclooxygenase-2, prostaglandin (PGE 2 ), inducible nitric oxide synthase, nuclear kappa B factor (NF-κB), transforming growth factor-β [TGF-β]). Glyburide treatment altered the mRNA expression of cellular jun (c-Jun), platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), chemokine-1 (CXCL1), chemokine-2 (CXCL2), tyrosine kinase with immunoglobulin-like and EGF-like domains Tyrosine Kinase (Tie-2), angiopoietin-1, mothers against decapentaplegic homolog 2 and 3 (Smad2/3), and Transforming growth factor-beta (TGF-β). CONCLUSION: The result clearly showed the protective effect of glyburide against STZ-induced diabetic wound via alteration of NF-κB/TGF-β and c-Jun/PDGF-VEGF Signaling Pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalWound HealingGlyburideHypoglycemic AgentsAnimalsRats, WistarSignal TransductionMaleNF-kappa BVascular Endothelial Growth Factor ARatsTransforming Growth Factor betaPlatelet-Derived Growth FactorStreptozocinOxidative Stress

Stichwörter der Autor:innen

Cellular jun/platelet-derived growth factor-vascular endothelial growth factor…diabetesinflammationoxidative stresswound healing

Substanzen

GlyburideNF-kappa BVascular Endothelial Growth Factor ATransforming Growth Factor betaHypoglycemic AgentsPlatelet-Derived Growth FactorStreptozocin

Autor:innen und Institutionen

  • Department of Plastic, Burn & Medical Cosmetic Surgery, The First Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi, China.
  • Department of Dermatology, Chang'an Hospital, Xi'an, Shaanxi, China.
  • Department of Dermatology, Xi'an Children's Hospital, Xi'an, Shaanxi, China.

Zitieren

APA

Fu, X., Wang, F., Zhang, W., Li, W., & Sun, X. (2026). Protective effect of glyburide on wound healing in streptozotocin-induced diabetic rats via alteration of NF-κB/transforming growth factor-β and cellular jun/platelet-derived growth factor-vascular endothelial growth factor signaling pathways. Indian Journal of Pharmacology, 58(6), 665-673. https://doi.org/10.4103/ijp.ijp_133_26

Vancouver

Fu X, Wang F, Zhang W, Li W, Sun X. Protective effect of glyburide on wound healing in streptozotocin-induced diabetic rats via alteration of NF-κB/transforming growth factor-β and cellular jun/platelet-derived growth factor-vascular endothelial growth factor signaling pathways. Indian Journal of Pharmacology. 2026;58(6):665-673. doi:10.4103/ijp.ijp_133_26

BibTeX
@article{Fu2026,
  author = {Fu, Xianjun and Wang, Fang and Zhang, Wei and Li, Wei and Sun, Xiaohong},
  title = {Protective effect of glyburide on wound healing in streptozotocin-induced diabetic rats via alteration of NF-κB/transforming growth factor-β and cellular jun/platelet-derived growth factor-vascular endothelial growth factor signaling pathways},
  journal = {Indian Journal of Pharmacology},
  year = {2026},
  volume = {58},
  number = {6},
  pages = {665--673},
  doi = {10.4103/ijp.ijp_133_26}
}
Kostenlos starten →